Define Ventures — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Lightship provides clinical trial operations for biopharma companies, CROs, and academic institutions, offering site services, decentralized and hybrid trial models, patient recruitment, and mobile research units.
BiotechDigital HealthHealthtechEl Segundo, US
David MacMurchy(Chief Executive Officer)inMichael Shipton(Chief Business Officer)inDarcy Forman(Chief Operating Officer)inLindsay Van Pelt(Chief Medical Advisor)in
Board seatLynne Chou O'Keefe· per SEC Form D
Co-investorsHikma VenturesALLEGIS CAPITALAlumni VenturesCongruentCongruent VenturesHyperguap+3 more
Chicago, US
Robert Alan Knight(Executive Officer, Director)Christopher Elliot Brown(Executive Officer)Jared Dauman(Executive Officer)James Daryl Risinger(Executive Officer, Director)
BoardCaitlin Donovan(Director)Galym Imanbayev(Director)in
Board seatLynne Chou O'Keefe· per SEC Form D · $54.2M raise · filed Dec 2024
Co-investorsLightspeed Venture PartnersQiming Healthcare
Chicago, US
Board seatLynne Chou O'Keefe· per SEC Form D
Co-investorsBlue Venture FundsGV (Google Ventures)Twine Ventures
Cohere Health provides a platform aimed at aligning the interests of patients, physicians, and health plans to support care decisions and improve member outcomes.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSBoston, US
Siva Namasivayam(Executive Officer, Director)Robert Shepardson(Executive Officer)Kristen Carucci(Executive Officer)Duncan Reese(Executive Officer)
BoardDavid Barrett(Director)Amir Debourou(Director)
Co-investorsCota CapitalFlare Capital PartnersLongitude CapitalDeerfield Management CompanyFlare Capital StrategiesTemasek
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.